Lars Ny
Impact in
- Gastroenterology top 2%
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
Papers in
- Oncology 42
- Cutaneous Melanoma Detection and Management 21
- Cancer Immunotherapy and Biomarkers 18
- CAR-T cell therapy research 16
-
- Ocular Oncology and Treatments 14
- Co-authors
- Lars Grundemar (7 shared papers)Jonas A. Nilsson (26 shared papers)Karl‐Erik Andersson (16 shared papers)Per Alm (11 shared papers)Roger Olofsson Bagge (45 shared papers)Henrik Jespersen (18 shared papers)Erik Larsson (3 shared papers)Nils Johan Fredriksson (1 shared paper)
- Journals
- British Journal of Pharmacology (8 papers)Acta Oncologica (6 papers)European Journal of Surgical Oncology (6 papers)Cancers (6 papers)The Journal of Urology (6 papers)
- Partner nations
- SwedenAustraliaUnited States
In The Last Decade
Lars Ny
111 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 124
- Gastroenterology 285
- Oncology 1.2k
- Ophthalmology 353
- Endocrine and Autonomic Systems 269
- Urology 197
Countries citing papers authored by Lars Ny
This map shows the geographic impact of Lars Ny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Ny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Ny more than expected).
Fields of papers citing papers by Lars Ny
This network shows the impact of papers produced by Lars Ny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Ny. The network helps show where Lars Ny may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Ny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 297 | |
| 2 | 2018 | 284 | |
| 3 | 2014 | 234 | |
| 4 | 2020 | 175 | |
| 5 | 1997 | 150 | |
| 6 | 2021 | 136 | |
| 7 | 2017 | 134 | |
| 8 | 2011 | 121 | |
| 9 | 2020 | 115 | |
| 10 | 2013 | 111 | |
| 11 | 2019 | 107 | |
| 12 | 2022 | 106 | |
| 13 | 2012 | 98 | |
| 14 | 2000 | 94 | |
| 15 | 1997 | 93 | |
| 16 | 2020 | 66 | |
| 17 | 1997 | 61 | |
| 18 | 1995 | 57 | |
| 19 | 2014 | 57 | |
| 20 | 2019 | 55 |
About Lars Ny
Lars Ny is a scholar working on Oncology, Ophthalmology, Endocrine and Autonomic Systems, Gastroenterology and Immunology, having authored 119 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (21 papers), Cancer Immunotherapy and Biomarkers (18 papers), Immunotherapy and Immune Responses (18 papers), CAR-T cell therapy research (16 papers), Ocular Oncology and Treatments (14 papers), Melanoma and MAPK Pathways (13 papers), Heme Oxygenase-1 and Carbon Monoxide (11 papers) and Gastroesophageal reflux and treatments (10 papers). The work is most often cited by research in Gastroenterology (285 citations), Oncology (1.2k citations), Ophthalmology (353 citations), Endocrine and Autonomic Systems (269 citations) and Urology (197 citations). Lars Ny has collaborated with scholars based in Sweden, Australia and United States. Frequent co-authors include Lars Grundemar, Jonas A. Nilsson, Karl‐Erik Andersson, Per Alm, Roger Olofsson Bagge, Henrik Jespersen, Erik Larsson, Nils Johan Fredriksson, Lisa M. Nilsson and Karl‐Erik Andersson. Their work appears in journals such as British Journal of Pharmacology, Acta Oncologica, European Journal of Surgical Oncology, Cancers and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.